We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03914625
Recruitment Status : Suspended (Other - FDA Partial Clinical Hold)
First Posted : April 16, 2019
Last Update Posted : January 12, 2023
Information provided by (Responsible Party):
National Cancer Institute (NCI)